Lazard Asset Management LLC Harvard Bioscience Inc Transaction History

Lazard Asset Management LLC

  • $68.3 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$4.19 - $6.16 $17,639 - $25,933
4,210 New
4,210 $23,000
Q3 2022

Nov 14, 2022
SELL
$2.33 - $3.92 $11,344 - $19,086
-4,869 Reduced 40.61%
7,120 $18,000
Q2 2022

Aug 09, 2022
BUY
$3.28 - $6.42 $15,970 - $31,258
4,869 Added 68.38%
11,989 $43,000
Q1 2022

May 13, 2022
BUY
$5.16 - $7.14 $25,624 - $35,457
4,966 Added 230.55%
7,120 $44,000
Q2 2021

Aug 12, 2021
BUY
$5.44 - $8.4 $11,717 - $18,093
2,154 New
2,154 $17,000

Others Institutions Holding HBIO

# of Institutions
97
Shares Held
30.6M
Call Options Held
700
Put Options Held
2.1K
View Full List

About HARVARD BIOSCIENCE INC

HBIO Quotes by TradingView
  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $89.1M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email